Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 69 Glioma 26 Brain Neoplasms 26 Gliosarcoma 23 Melanoma 17 Central Nervous System Neoplasms 14 Astrocytoma 12 Neuroblastoma 10 Rhabdomyosarcoma 8 Small Cell Lung Carcinoma 6 Sarcoma, Ewing 6 Neoplasms 6 Neoplasm Metastasis 6 Medulloblastoma 6 Recurrence 5 Sarcoma 4 Ovarian Neoplasms 4 Osteosarcoma 4 Oligodendroglioma 4 Wilms Tumor 3 Prostatic Neoplasms 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Ependymoma 3 Diffuse Intrinsic Pontine Glioma 3 Breast Neoplasms 3 Rhabdoid Tumor 2 Pancreatic Neoplasms 2 Optic Nerve Glioma 2 Lymphoma, Follicular 2 Lymphoma 2

Interventions

Temozolomide 1 Sulfasalazine 1 Sirolimus 1 Radiotherapy 1 Memantine 1 Gabapentin 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Epilepsy × Temozolomide × Clear all

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡